JUPITER, Fla., Jan. 19, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. ("Dyadic", or the "Company") (NASDAQ: DYAI), a global biotechnology company focused on building innovative microbial platforms to address the growing demand for…
DUBLIN--(BUSINESS WIRE)--The "China Bispecific Antibody Market Opportunity & Clinical Trials Insight 2028" report has been added to ResearchAndMarkets.com's offering.
At present, there are 3 bispecific antibodies which have got…